dual inhibitors of sphingosine kinase 1 and 2 (Shandong Academy of Medical Science/Chinese Academy of Medical Sciences & Peking Union Medical College/Shandong University)

N/A

Report date: 2025/01/26 16:22:15
NME

Base Information

Drug Namedual inhibitors of sphingosine kinase 1 and 2 (Shandong Academy of Medical Science/Chinese Academy of Medical Sciences & Peking Union Medical College/Shandong University)
Drug Alias Name2-Epi-Jaspine B Analogs (SPHK1/2 Inhibitors) (Shandong Academy of Medical Science/Chinese Academy of Medical Sciences & Peking Union Medical College/Shandong University)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSphingosine kinase 2 inhibitorsSphingosine kinase 1 inhibitors
TargetsSphingosine kinase 2Sphingosine kinase 1
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShandong Academy Of Medical Sciences
China Registration ClassN/A

Develop Information

Active CompaniesShandong Academy Of Medical SciencesChinese Academy Of Medical Science & Peking Union Medical CollegeShandong University
Inactive CompaniesN/A
Active IndicationsArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A